Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SITAGRAMI: Sitagliptin + G-CSF in Acute Myocardial Infarction
NCT00650143Phase 3Completed
- Sponsor
- Ludwig Maximilian University of Munich
- Start
- Mar 2008
- Primary completion
- Jun 2012
- Modality
- Cytokines & Interferons, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sitagliptin, lenograstim in acute myocardial infarction (AMI), sponsored by Ludwig Maximilian University of Munich. Started Mar 2008; status: completed.
02
Drugs
sitagliptinlenograstim
03
Conditions
acute myocardial infarction (AMI)
Beyond the preview
Go deeper on NCT00650143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00650143.